Showing results (71-80 of 79) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Anesthesiology|December 18, 1998
Obstetric postanesthesia care unit stays: reevaluation of discharge criteria after regional anesthesiaS E Cohen, C L Hamilton, E T Riley, et al.Analytical Chemistry|June 10, 2011
Remotely detected NMR for the characterization of flow and fast chromatographic separations using organic polymer monolithsThomas Z Teisseyre, Jiri Urban, Nicholas W Halpern-Manners, et al.Circulation|April 1, 1981
Application of information theory to clinical diagnostic testing. The electrocardiographic stress testG A Diamond, M Hirsch, J S Forrester, et al.IARC Scientific Publications|January 1, 1978
Cellular immunity in infectious mononucleosis: I. Spontaneous and phytohaemagglutinin-induced blast transformation in infectious mononucleosis, with special reference to depressed cellular reactivity and stimulation-blocking serum factorsJ Nikoskelainen, D A Stevens, E U Neel, et al.Journal of Magnetic Resonance (San Diego, Calif. : 1997)|December 3, 2014
Gradient-free microfluidic flow labeling using thin magnetic films and remotely detected MRINicholas W Halpern-Manners, Daniel J Kennedy, David R Trease, et al.Applied Magnetic Resonance|August 21, 2023
Measurement of Arterial Input Function in Hyperpolarized 13C StudiesMałgorzata Marjańska, Thomas Z Teisseyre, Nicholas W Halpern-Manners, et al.Journal of Pain and Symptom Management|August 4, 2010
Contribution of a heating element to topical anesthesia patch efficacy prior to vascular access: results from two randomized, double-blind studiesSalman Masud, Richard D Wasnich, Jon L Ruckle, et al.Proceedings of the National Academy of Sciences of the United States of America|September 15, 2005
Reversible inhibition of copper amine oxidase activity by channel-blocking ruthenium(II) and rhenium(I) molecular wiresStephen M Contakes, Gregory A Juda, David B Langley, et al.British Journal of Cancer|November 18, 2010
A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphomaA Younes, J M Vose, A D Zelenetz, et al.Pageof 8